市場調查報告書
商品編碼
1380446
全球無創減脂市場2023-2030Global Non-Invasive Fat Reduction Market 2023-2030 |
預計全球非侵入性減脂市場在預測期內(2023-2030年)將以7.8%的CAGR成長。推動市場成長的關鍵因素包括肥胖盛行率上升、健康風險意識不斷增強、對微創手術的需求不斷成長以及非侵入性減脂手術的採用率不斷上升。根據國際美容整形外科學會的數據,2022 年非手術減脂手術總數為 778,716 例,較 2021 年的 730,980 例有所增加。此外,一項調查顯示,85% 的人有一個開始思考更多的季節關於擺脫頑固的身體脂肪,對於其中40% 的人來說,這個季節就是春天。此外,92% 的人希望得到幫助讓自己的身體為夏季做好準備。因此,製造商正在推出活動來鼓勵那些正在尋求非侵入性減脂治療的人。例如,2023 年 4 月,AbbVie 旗下公司、CoolSculpting (R) Elite 的母公司 Allergan Aesthetics 推出了首個 CoolMonth。 CoolMonth 活動鼓勵正在考慮非侵入性塑身治療的人們與值得信賴的醫療保健提供者進行對話,並就如何實現其塑身目標進行公開對話。
全球非侵入性減脂市場按技術和最終用戶進行細分。根據技術,市場細分為冷凍溶脂、超音波等。此外,根據最終用戶,市場細分為醫院、美容診所等。在最終用戶中,由於設備齊全、交通便利、信任和可靠,預計醫院細分市場將佔據相當大的市場佔有率。
其中,冷凍溶脂細分領域預計將在全球非侵入性減脂市場中佔據相當大的佔有率。細分市場的成長歸因於副作用最小,以及對安全、快速和非侵入性治療的需求不斷成長。根據國家醫學圖書館的研究,冷凍溶脂是一種有前景的非手術減脂方法,是抽脂和其他侵入性方法的替代方法。該手術在短期內似乎是安全的,副作用有限,並且當用於局部肥胖時可顯著減少脂肪。目前尚不清楚治療後手動按摩和同一解剖區域的多次治療是否可以增強冷凍溶脂的功效。
全球非侵入性減脂市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,亞太地區預計將在全球市場中佔據顯著佔有率,因為隨著人們對美容治療益處的認知不斷提高、對完美外表和通過身體特徵獲得自信的渴望不斷增強,以及新興經濟體城市化帶來的可支配收入的增加和生活方式的改變,正在推動亞太地區的非侵入性減脂市場。
在所有地區中,歐洲地區預計在預測期內將以相當大的CAGR成長。由於肥胖病例增加和微創手術擴大採用等因素,歐洲市場正在成長。根據國際美容整形外科學會2022年報告,2022年,英國非手術減脂手術總數為2,142例,其次是德國非手術減脂手術總數為26,989例,在義大利,非手術減脂手術總數為 13,071 例。此外,市場參與者高度集中於關鍵產品的推出和收購以及擴大歐洲市場的合作夥伴關係是推動該地區非侵入性減脂市場成長的一些因素。例如,2020 年 9 月,美容、外科和眼科應用領域的能源醫療設備先驅 Lumenis Ltd. 在歐洲和中東提供了採用 FocalRF 技術的革命性 NuEra Tight。 NuEraight 為塑身帶來了全新的意義,它提供了一種個人化解決方案,可實現非侵入性、射頻、減脂、緊膚、脂肪團和皺紋減少,所有功能都在一台裝置中。
服務於非侵入性減脂市場的主要公司包括: AbbVie Inc. (Allergan Aesthetics)、Alma Lasers Ltd.、Bausch Health Companies Inc.、Candela Corp.、Cutera Inc.、Cynosure Inc.、Lumenis Be Ltd、BTL Aesthetics , 和別的。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022 年 4 月,皮膚科解決方案提供商 CUTERA, INC. 與消費者支付和融資解決方案提供商 Synchrony 合作,將患者融資選擇擴展到美國各地的皮膚科實踐。
Title: Global Non-Invasive Fat Reduction Market Size, Share & Trends Analysis Report by Type (Cryolipolysis, Ultrasound, and Others), and by End-User (Hospitals, Cosmetic and Aesthetic Clinics and Others),Forecast Period (2023-2030).
The global non-invasive fat reduction market is anticipated to grow at a CAGR of 7.8% during the Forecast Period (2023-2030). Pivotal factors driving the market growth including the rising prevalence of obesity, growing awareness of health risks, growing demand for minimally invasive procedures and, rising adoption of non-invasive fat reduction procedures. According to the International Society of Aesthetic Plastic Surgery, in 2022, total non-surgical fat reduction procedures performed was 778,716 which was increased from 730,980 in 2021. Further, a survey revealed 85% of people have a season in which they begin to think more about getting rid of stubborn body fat, and for 40% of those people, that season is spring. In addition, 92% of people would like help getting their body ready for summer. Thus, manufacturers are introducing activities to encourage people who are looking for a non-invasive fat reduction treatment. For instance, in April 2023, Allergan Aesthetics, an AbbVie company and the parent company of CoolSculpting® Elite, launched the first ever CoolMonth. CoolMonth activities encouraged people who are considering a non-invasive body contouring treatment to have a conversation with a trusted healthcare provider and an open dialogue about what is realistic for their body contouring goals.
The global non-invasive fat reduction market is segmented on the technology, and end user. Based on the technology, the market is sub-segmented into cryolipolysis, ultrasound and others. Further, on the basis of end user, the market is sub-segmented into hospitals, cosmetic and aesthetic clinics and others. Among the end user, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easily accessible, trust and reliability.
Among the technology, the cryolipolysis sub-segment is expected to hold a considerable share of the global non-invasive fat reduction market. The segmental growth is attributed to the minimal side effects, growing demand for safe, fast and non-invasive treatment. According to the study of National Library of Medicine, cryolipolysis is a promising procedure for nonsurgical fat reduction and presents an alternative to liposuction and other invasive methods. This procedure appears to be safe in the short term, with a limited side effect profile, and results in significant fat reduction when used for localized adiposities. It remains unclear whether posttreatment manual massage and multiple treatments in the same anatomic area enhance the efficacy of cryolipolysis.
The global non-invasive fat reduction market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing awareness about the benefits of aesthetic treatments, increasing desire for perfect appearance and confidence through physical characteristics and the rising disposable income and changes in lifestyles owing to urbanization in emerging economies are driving the non-invasive fat reduction market in the Asia Pacific.
Among all regions, the Europe regions is anticipated to grow at a considerable CAGR over the forecast period. The Europe market is growing due to factors such as the rising cases of obesity and the increasing adoption of minimally invasive procedures. According to the International Society of Aesthetic Plastic Surgery 2022 report, in 2022, in the UK, the total number of non-surgical fat reduction procedures performed was 2,142 followed by in Germany the total number of non-surgical fat reduction procedures performed was 26,989, in Italy, the total number of non-surgical fat reduction procedures performed 13,071. Further, the high concentration of market players on Key product launches and acquisitions and partnerships to expand the market in the Europe are some of the factors driving the growth of the non-invasive fat reduction market in the region. For instance, in September 2020, Lumenis Ltd., the pioneer in energy-based medical device company for aesthetic, surgical and ophthalmic applications, provided the revolutionary NuEra Tight with FocalRF technology in Europe and the Middle East. Body Sculpting took a whole new meaning with NuEra tight offering a personalized solution for non-invasive, radio frequency, fat reduction, skin tightening, cellulite and wrinkle reduction, all in one device.
The major companies serving the non-invasive fat reduction market include: AbbVie Inc. (Allergan Aesthetics), Alma Lasers Ltd., Bausch Health Companies Inc., Candela Corp., Cutera Inc., Cynosure Inc., Lumenis Be Ltd, BTL Aesthetics, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, CUTERA, INC., a provider of dermatological solutions, and Synchrony, a provider of consumer payment and financing solutions, partnered to expand patient financing options to dermatology practices across the US.